Scot Harper
Hoofd Techniek/Wetenschap/O&O bij RADIOPHARM THERANOSTICS LIMITED
Actieve functies van Scot Harper
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-12-2021 | - |
Loopbaan van Scot Harper
Eerdere bekende functies van Scot Harper
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ENDOCYTE, INC. | Hoofd Techniek/Wetenschap/O&O | 07-05-2013 | 28-10-2016 |
| Corporate Officer/Principal | 07-05-2013 | 14-05-2014 |
Opleiding van Scot Harper
| University of South Alabama | Graduate Degree |
| DePauw University | Undergraduate Degree |
| The Indiana University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Australië | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RADIOPHARM THERANOSTICS LIMITED | Health Services |
| Bedrijven in privébezit | 1 |
|---|---|
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
- Beurs
- Insiders
- Scot Harper
- Ervaring
